TNF Inhibition for Ophthalmic Indications: Current Status and Outlook

@article{Rifkin2013TNFIF,
  title={TNF Inhibition for Ophthalmic Indications: Current Status and Outlook},
  author={Lana M. Rifkin and Andrea D. Birnbaum and D. Goldstein},
  journal={BioDrugs},
  year={2013},
  volume={27},
  pages={347-357}
}
  • Lana M. Rifkin, Andrea D. Birnbaum, D. Goldstein
  • Published 2013
  • Medicine
  • BioDrugs
  • BackgroundTumor necrosis factors (TNF) are a group of cytokines that play a role in systemic inflammation, stimulating the acute phase reaction. They are involved in systemic rheumatologic conditions such as rheumatoid arthritis and juvenile idiopathic arthritis, as well as ocular inflammatory conditions in the uveitis spectrum. Several drugs were developed to inhibit the action of TNF, thereby reducing inflammation. The three most commonly used TNF inhibitors in the US are etanercept… CONTINUE READING
    25 Citations
    Biological Therapies that Target Inflammatory Cytokines to Treat Uveitis
    • 1
    Paradoxical effects of anti-TNF-α agents in inflammatory diseases
    • 72
    Tumor necrosis factor inhibitors – state of knowledge
    • 89
    • PDF
    Therapeutic targets for rheumatoid arthritis: Progress and promises
    • 76
    Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    • 30
    The Promise and Limitations of TNF-α Inhibition for Uveitis
    • 1
    Tumor Necrosis Factor-&agr; Inhibitors as a Treatment of Corneal Hemangiogenesis and Lymphangiogenesis
    • 16

    References

    SHOWING 1-10 OF 90 REFERENCES
    Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
    • 349
    Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    • 209
    New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseases.
    • 102
    Drug therapy of inflammatory arthritis.
    • 7
    • PDF
    Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial
    • 99
    Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis
    • 40
    A PEGylated Fab’ Fragment against Tumor Necrosis Factor for the Treatment of Crohn Disease
    • 54